Actively Recruiting
Use of Mechanical Left ventricuLar Unloading in Complex Higher-risk Indicated Procedures
Led by Amsterdam UMC, location VUmc · Updated on 2026-02-02
98
Participants Needed
8
Research Sites
161 weeks
Total Duration
On this page
Sponsors
A
Amsterdam UMC, location VUmc
Lead Sponsor
P
Pulsecath BV.
Collaborating Sponsor
AI-Summary
What this Trial Is About
If there is a narrowing or blockage in the coronary arteries of the heart, the cardiologist may choose to treat this blockage. This is called percutaneous coronary intervention (PCI), which involves both balloon angioplasty and the placement of a stent. PCI is a commonly performed and safe procedure. However, in your case, the procedure is more complicated than usual due to the location and nature of the narrowing, the required technique for the intervention, and the fact that your heart function is reduced. As a result, your PCI will carry a higher risk than usual. During the procedure, balloons are inflated to clear the blockage, and a stent is placed to keep the artery open. This temporarily reduces or even stops the blood and oxygen supply to a large portion of the heart. This moment presents a higher risk for complications, such as low blood pressure or cardiac arrest. As a result, the heart may not pump blood effectively throughout the body, which can lead to oxygen deprivation in other organs. To help the heart in this situation, it is possible to insert a mechanical heart pump during the procedure. This form of support is introduced via an artery in the groin into your left ventricle. The pump helps the heart function and may improve the circulation to the body's organs. On the other hand, the placement of the pump increases the chance of complications. Therefore, there are both potential benefits and risks. It is currently unclear whether PCI with the temporary pump can be performed more safely than without it. This study aims to investigate whether mechanical circulatory support, specifically with the Pulsecath iVAC2L, leads to improved outcomes for patients undergoing high-risk PCI.
CONDITIONS
Official Title
Use of Mechanical Left ventricuLar Unloading in Complex Higher-risk Indicated Procedures
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Multidisciplinary heart team consensus for high-risk PCI with or without mechanical circulatory support
- Hemodynamically stable (SCAI stage A-B)
- Left ventricular ejection fraction (LVEF) less than 30%, or LVEF less than 35% with moderate mitral regurgitation, or LVEF less than 40% with severe mitral regurgitation
- Complex left main coronary disease requiring calcium modifying techniques or two-stent techniques, left dominant system, equivalent lesions (ostial LAD and RCX), or last remaining native vessel
You will not qualify if you...
- Severe aortic regurgitation
- Presence of left ventricular thrombus detected by imaging
- Mechanical aortic valve prosthesis
- Severe aortic valve stenosis
- Peripheral arterial disease preventing placement of the Pulsecath iVAC2L device
- Cardiogenic shock (SCAI CSWG stage C-E)
- Patient is intubated and mechanically ventilated
- Stroke within the past 3 months
- Major bleeding event within the past 3 months
- History of bleeding disorders or coagulopathy, recent genitourinary or gastrointestinal bleeding, or refusal of blood transfusions
- Currently receiving renal replacement therapy
- Pregnancy or suspected pregnancy
- Body mass index greater than 35
- Other medical, social, or psychological conditions that impair ability to consent or comply with study procedures
- Belonging to a vulnerable population such as individuals with mental disability, nursing home residents, homeless persons, refugees, or others unable to give informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
Amsterdam University Medical Center
Amsterdam, Netherlands
Actively Recruiting
2
Zuyderland
Geleen, Netherlands
Actively Recruiting
3
University Medical Center Groningen
Groningen, Netherlands
Actively Recruiting
4
Leiden University Medical Center
Leiden, Netherlands
Actively Recruiting
5
Maastricht University Medical Center
Maastricht, Netherlands
Actively Recruiting
6
Radboud University Medical Center
Nijmegen, Netherlands
Actively Recruiting
7
Haaglanden Medical Center
The Hague, Netherlands
Actively Recruiting
8
University Medical Center Utrecht
Utrecht, Netherlands
Actively Recruiting
Research Team
A
Alexander Nap, MD, PhD
CONTACT
T
Tijmen H. Ris, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here